40/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q21/3 |
LoseFBIO / S&P 9.68% / 15.20% |
WinFBIO / S&P 20.68% / 15.00% |
LoseFBIO / S&P -351.43% / 50.40% |
Non-scoringFBIO / S&P 167.26% / 15.70% | Non-scoringFBIO / S&P 0.91 / 28.47 | Non-scoringFBIO / S&P 0.62 / S&P unavailable | Non-scoringFBIO / S&P FBIO unavailable / S&P unavailable | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.36b |
| 2026-Q11/3 |
LoseFBIO / S&P -23.77% / -4.33% |
WinFBIO / S&P 15.89% / 11.30% |
LoseFBIO / S&P -242.15% / 27.70% |
Non-scoringFBIO / S&P 199.58% / 14.80% | Non-scoringFBIO / S&P 0.72 / 25.43 | Non-scoringFBIO / S&P 0.57 / S&P unavailable | Non-scoringFBIO / S&P FBIO unavailable / S&P unavailable | Non-scoringFBIO / S&P FBIO unavailable / $0.27b | Non-scoringFBIO / S&P FBIO unavailable / $0.00b |
| 2025-Q41/3 |
LoseFBIO / S&P -1.08% / 2.65% |
WinFBIO / S&P 11.07% / 9.00% |
LoseFBIO / S&P -95.34% / 13.40% |
Non-scoringFBIO / S&P 11.13% / 13.20% | Non-scoringFBIO / S&P 16.84 / 28.48 | Non-scoringFBIO / S&P 2.30 / 5.39 | Non-scoringFBIO / S&P FBIO unavailable / $4.42m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.20b |
| 2025-Q31/3 |
WinFBIO / S&P 98.92% / 8.12% |
LoseFBIO / S&P 0.04% / 4.61% |
LoseFBIO / S&P -94.12% / 13.45% |
Non-scoringFBIO / S&P 6.90% / 11.78% | Non-scoringFBIO / S&P 28.77 / 28.13 | Non-scoringFBIO / S&P 2.05 / 5.27 | Non-scoringFBIO / S&P FBIO unavailable / $4.42m | Non-scoringFBIO / S&P FBIO unavailable / $0.11b | Non-scoringFBIO / S&P FBIO unavailable / $0.00b |
| 2025-Q21/3 |
WinFBIO / S&P 19.23% / 10.94% |
LoseFBIO / S&P -5.18% / 4.83% |
LoseFBIO / S&P -67.59% / 10.63% |
Non-scoringFBIO / S&P -26.59% / 11.45% | Non-scoringFBIO / S&P FBIO unavailable / 27.10 | Non-scoringFBIO / S&P 1.26 / 5.01 | Non-scoringFBIO / S&P FBIO unavailable / $4.42m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.23b |
| 2025-Q10/3 |
LoseFBIO / S&P -23.15% / -4.27% |
LoseFBIO / S&P -8.73% / 4.98% |
LoseFBIO / S&P -63.80% / 10.57% |
Non-scoringFBIO / S&P -74.51% / 11.39% | Non-scoringFBIO / S&P FBIO unavailable / 26.23 | Non-scoringFBIO / S&P 2.07 / 4.69 | Non-scoringFBIO / S&P FBIO unavailable / $4.42m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.10b |
| 2024-Q41/3 |
WinFBIO / S&P 40.00% / 2.41% |
LoseFBIO / S&P -7.59% / 5.25% |
LoseFBIO / S&P -47.65% / 6.15% |
Non-scoringFBIO / S&P -83.43% / 11.29% | Non-scoringFBIO / S&P FBIO unavailable / 28.60 | Non-scoringFBIO / S&P 2.49 / 4.99 | Non-scoringFBIO / S&P FBIO unavailable / $4.28m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.08b |
| 2024-Q30/3 |
LoseFBIO / S&P -15.20% / 5.89% |
LoseFBIO / S&P -4.24% / 5.89% |
LoseFBIO / S&P -68.19% / 6.11% |
Non-scoringFBIO / S&P -83.97% / 10.87% | Non-scoringFBIO / S&P FBIO unavailable / 28.09 | Non-scoringFBIO / S&P 1.89 / 4.94 | Non-scoringFBIO / S&P FBIO unavailable / $4.28m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.21b |
| 2024-Q20/3 |
LoseFBIO / S&P -14.50% / 4.28% |
LoseFBIO / S&P -4.37% / 5.38% |
LoseFBIO / S&P -74.67% / 5.12% |
Non-scoringFBIO / S&P -69.65% / 10.85% | Non-scoringFBIO / S&P FBIO unavailable / 27.64 | Non-scoringFBIO / S&P 2.16 / 4.79 | Non-scoringFBIO / S&P FBIO unavailable / $4.28m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.36b |
| 2024-Q10/3 |
LoseFBIO / S&P -33.55% / 10.56% |
LoseFBIO / S&P -2.95% / 5.71% |
LoseFBIO / S&P -34.47% / 5.59% |
Non-scoringFBIO / S&P -90.07% / 10.81% | Non-scoringFBIO / S&P FBIO unavailable / 27.02 | Non-scoringFBIO / S&P 1.68 / 4.71 | Non-scoringFBIO / S&P FBIO unavailable / $4.28m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.12b |
| 2023-Q40/3 |
LoseFBIO / S&P -30.80% / 11.69% |
LoseFBIO / S&P -15.96% / 6.81% |
LoseFBIO / S&P -43.12% / 7.78% |
Non-scoringFBIO / S&P -101.63% / 11.19% | Non-scoringFBIO / S&P FBIO unavailable / 24.35 | Non-scoringFBIO / S&P 2.02 / 4.31 | Non-scoringFBIO / S&P FBIO unavailable / $4.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.01b |
| 2023-Q31/3 |
LoseFBIO / S&P -47.27% / -3.27% |
LoseFBIO / S&P -16.90% / 7.52% |
WinFBIO / S&P 95.13% / -5.03% |
Non-scoringFBIO / S&P -129.80% / 10.84% | Non-scoringFBIO / S&P FBIO unavailable / 23.93 | Non-scoringFBIO / S&P 2.33 / 3.98 | Non-scoringFBIO / S&P FBIO unavailable / $4.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.24b |
| 2023-Q21/3 |
LoseFBIO / S&P -32.93% / 8.74% |
LoseFBIO / S&P -19.79% / 9.50% |
WinFBIO / S&P 1084.26% / -8.57% |
Non-scoringFBIO / S&P -156.77% / 10.88% | Non-scoringFBIO / S&P FBIO unavailable / 24.01 | Non-scoringFBIO / S&P 58.68 / 4.19 | Non-scoringFBIO / S&P FBIO unavailable / $4.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.17b |
| 2023-Q12/3 |
WinFBIO / S&P 24.24% / 7.50% |
LoseFBIO / S&P -14.82% / 10.77% |
WinFBIO / S&P 993.02% / -15.69% |
Non-scoringFBIO / S&P -148.09% / 10.82% | Non-scoringFBIO / S&P FBIO unavailable / 22.66 | Non-scoringFBIO / S&P 42.44 / 3.93 | Non-scoringFBIO / S&P FBIO unavailable / $4.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.13b |
| 2022-Q42/3 |
LoseFBIO / S&P -23.26% / 7.56% |
WinFBIO / S&P 12.45% / 11.88% |
WinFBIO / S&P 1086.08% / -17.99% |
Non-scoringFBIO / S&P -121.95% / 11.09% | Non-scoringFBIO / S&P FBIO unavailable / 22.65 | Non-scoringFBIO / S&P 1.75 / 3.75 | Non-scoringFBIO / S&P FBIO unavailable / $3.70m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.15b |
| 2022-Q32/3 |
WinFBIO / S&P 2.38% / -4.88% |
WinFBIO / S&P 22.33% / 13.47% |
LoseFBIO / S&P FBIO unavailable / -1.41% |
Non-scoringFBIO / S&P -125.62% / 12.28% | Non-scoringFBIO / S&P FBIO unavailable / 20.58 | Non-scoringFBIO / S&P 22.65 / 3.60 | Non-scoringFBIO / S&P FBIO unavailable / $3.70m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.17b |
| 2022-Q21/3 |
LoseFBIO / S&P -38.24% / -16.10% |
WinFBIO / S&P 54.87% / 13.71% |
LoseFBIO / S&P FBIO unavailable / 11.04% |
Non-scoringFBIO / S&P -117.47% / 13.03% | Non-scoringFBIO / S&P FBIO unavailable / 20.28 | Non-scoringFBIO / S&P 17.58 / 3.78 | Non-scoringFBIO / S&P FBIO unavailable / $3.70m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.17b |
| 2022-Q11/3 |
LoseFBIO / S&P -45.60% / -4.60% |
WinFBIO / S&P 69.06% / 15.97% |
LoseFBIO / S&P FBIO unavailable / 42.23% |
Non-scoringFBIO / S&P -97.86% / 14.22% | Non-scoringFBIO / S&P FBIO unavailable / 22.19 | Non-scoringFBIO / S&P 22.16 / 4.51 | Non-scoringFBIO / S&P FBIO unavailable / $3.70m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.20b |
| 2021-Q41/3 |
LoseFBIO / S&P -22.36% / 11.03% |
WinFBIO / S&P 41.78% / 15.00% |
LoseFBIO / S&P FBIO unavailable / 96.40% |
Non-scoringFBIO / S&P -102.49% / 15.13% | Non-scoringFBIO / S&P FBIO unavailable / 23.63 | Non-scoringFBIO / S&P 35.00 / 4.73 | Non-scoringFBIO / S&P FBIO unavailable / $3.63m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.13b |
| 2021-Q31/3 |
LoseFBIO / S&P -9.80% / 0.58% |
WinFBIO / S&P 41.58% / 10.77% |
LoseFBIO / S&P FBIO unavailable / 69.42% |
Non-scoringFBIO / S&P -64.77% / 14.13% | Non-scoringFBIO / S&P FBIO unavailable / 25.35 | Non-scoringFBIO / S&P 51.46 / 4.38 | Non-scoringFBIO / S&P FBIO unavailable / $3.63m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.19b |
| 2021-Q21/3 |
LoseFBIO / S&P 1.13% / 8.55% |
WinFBIO / S&P 17.21% / 6.58% |
LoseFBIO / S&P FBIO unavailable / 51.81% |
Non-scoringFBIO / S&P -67.51% / 13.34% | Non-scoringFBIO / S&P FBIO unavailable / 26.70 | Non-scoringFBIO / S&P 48.22 / 4.43 | Non-scoringFBIO / S&P FBIO unavailable / $3.63m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.11b |
| 2021-Q12/3 |
WinFBIO / S&P 11.36% / 6.17% |
WinFBIO / S&P 6.29% / -1.06% |
LoseFBIO / S&P FBIO unavailable / 7.39% |
Non-scoringFBIO / S&P -99.25% / 11.60% | Non-scoringFBIO / S&P FBIO unavailable / 30.50 | Non-scoringFBIO / S&P 48.63 / 4.23 | Non-scoringFBIO / S&P FBIO unavailable / $3.63m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.10b |
| 2020-Q41/3 |
LoseFBIO / S&P -21.53% / 12.15% |
WinFBIO / S&P 27.52% / -3.72% |
LoseFBIO / S&P FBIO unavailable / -33.42% |
Non-scoringFBIO / S&P -104.48% / 8.86% | Non-scoringFBIO / S&P FBIO unavailable / 39.26 | Non-scoringFBIO / S&P 44.96 / 4.05 | Non-scoringFBIO / S&P FBIO unavailable / $3.17m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.01b |
| 2020-Q32/3 |
WinFBIO / S&P 50.75% / 8.93% |
WinFBIO / S&P 40.53% / -2.04% |
LoseFBIO / S&P FBIO unavailable / -27.10% |
Non-scoringFBIO / S&P -135.34% / 9.24% | Non-scoringFBIO / S&P FBIO unavailable / 34.27 | Non-scoringFBIO / S&P 58.50 / 3.65 | Non-scoringFBIO / S&P FBIO unavailable / $3.17m | Non-scoringFBIO / S&P FBIO unavailable / $0.02b | Non-scoringFBIO / S&P FBIO unavailable / $0.00b |
| 2020-Q22/3 |
WinFBIO / S&P 41.80% / 20.54% |
WinFBIO / S&P 64.53% / -0.46% |
LoseFBIO / S&P FBIO unavailable / -27.11% |
Non-scoringFBIO / S&P -128.55% / 9.37% | Non-scoringFBIO / S&P FBIO unavailable / 31.29 | Non-scoringFBIO / S&P 57.24 / 3.44 | Non-scoringFBIO / S&P FBIO unavailable / $3.17m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.03b |
| 2020-Q11/3 |
LoseFBIO / S&P -26.46% / -19.60% |
WinFBIO / S&P 69.81% / 3.47% |
LoseFBIO / S&P FBIO unavailable / -14.75% |
Non-scoringFBIO / S&P -131.86% / 10.68% | Non-scoringFBIO / S&P FBIO unavailable / 22.80 | Non-scoringFBIO / S&P 59.83 / 2.92 | Non-scoringFBIO / S&P FBIO unavailable / $3.17m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.05b |
| 2019-Q42/3 |
WinFBIO / S&P 82.27% / 9.07% |
WinFBIO / S&P 49.39% / 5.36% |
LoseFBIO / S&P FBIO unavailable / 2.99% |
Non-scoringFBIO / S&P -114.43% / 12.81% | Non-scoringFBIO / S&P FBIO unavailable / 22.78 | Non-scoringFBIO / S&P 108.86 / 3.53 | Non-scoringFBIO / S&P FBIO unavailable / $3.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.05b |
| 2019-Q30/3 |
LoseFBIO / S&P -6.00% / 1.70% |
LoseFBIO / S&P -127.27% / 5.02% |
LoseFBIO / S&P FBIO unavailable / 0.21% |
Non-scoringFBIO / S&P -165.45% / 12.41% | Non-scoringFBIO / S&P FBIO unavailable / 22.44 | Non-scoringFBIO / S&P 57.67 / 3.30 | Non-scoringFBIO / S&P FBIO unavailable / $3.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.09b |
| 2019-Q20/3 |
LoseFBIO / S&P -15.73% / 4.30% |
LoseFBIO / S&P -137.69% / 6.64% |
LoseFBIO / S&P FBIO unavailable / 8.65% |
Non-scoringFBIO / S&P -208.71% / 12.79% | Non-scoringFBIO / S&P FBIO unavailable / 21.37 | Non-scoringFBIO / S&P 40.83 / 3.32 | Non-scoringFBIO / S&P FBIO unavailable / $3.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.27b |
| 2019-Q11/3 |
WinFBIO / S&P 106.98% / 13.65% |
LoseFBIO / S&P -201.43% / 8.12% |
LoseFBIO / S&P FBIO unavailable / 14.29% |
Non-scoringFBIO / S&P -257.32% / 12.97% | Non-scoringFBIO / S&P FBIO unavailable / 20.86 | Non-scoringFBIO / S&P 80.97 / 3.26 | Non-scoringFBIO / S&P FBIO unavailable / $3.08m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $34.35b |
| 2018-Q41/3 |
LoseFBIO / S&P -46.25% / -13.52% |
WinFBIO / S&P 50.62% / 9.05% |
LoseFBIO / S&P FBIO unavailable / 18.23% |
Non-scoringFBIO / S&P -359.97% / 13.10% | Non-scoringFBIO / S&P FBIO unavailable / 19.39 | Non-scoringFBIO / S&P 402.92 / 2.94 | Non-scoringFBIO / S&P FBIO unavailable / $3.00m | Non-scoringFBIO / S&P FBIO unavailable / $0.01b | Non-scoringFBIO / S&P FBIO unavailable / $0.00b |
| 2018-Q30/3 |
LoseFBIO / S&P -46.31% / 7.71% |
LoseFBIO / S&P -170.62% / 10.21% |
LoseFBIO / S&P FBIO unavailable / 19.06% |
Non-scoringFBIO / S&P 63.71% / 13.01% | Non-scoringFBIO / S&P FBIO unavailable / 22.25 | Non-scoringFBIO / S&P 35.70 / 3.45 | Non-scoringFBIO / S&P FBIO unavailable / $3.00m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.17b |
| 2018-Q20/3 |
LoseFBIO / S&P -34.51% / 3.43% |
LoseFBIO / S&P -162.09% / 9.03% |
LoseFBIO / S&P FBIO unavailable / 14.46% |
Non-scoringFBIO / S&P 118.47% / 12.56% | Non-scoringFBIO / S&P FBIO unavailable / 22.49 | Non-scoringFBIO / S&P 54.93 / 3.25 | Non-scoringFBIO / S&P FBIO unavailable / $3.00m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.19b |
| 2018-Q11/3 |
WinFBIO / S&P 14.04% / -0.76% |
LoseFBIO / S&P -139.09% / 7.68% |
LoseFBIO / S&P FBIO unavailable / 12.46% |
Non-scoringFBIO / S&P 320.94% / 12.27% | Non-scoringFBIO / S&P FBIO unavailable / 23.41 | Non-scoringFBIO / S&P 86.33 / 3.17 | Non-scoringFBIO / S&P FBIO unavailable / $3.00m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.08b |
| 2017-Q40/3 |
LoseFBIO / S&P -9.73% / 6.64% |
LoseFBIO / S&P -5.83% / 7.03% |
LoseFBIO / S&P FBIO unavailable / 13.82% |
Non-scoringFBIO / S&P -430.90% / 12.09% | Non-scoringFBIO / S&P FBIO unavailable / 24.25 | Non-scoringFBIO / S&P 58.05 / 3.23 | Non-scoringFBIO / S&P FBIO unavailable / $2.92m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.05b |
| 2017-Q31/3 |
LoseFBIO / S&P -6.95% / 4.48% |
WinFBIO / S&P 3584.99% / 5.68% |
LoseFBIO / S&P FBIO unavailable / 17.57% |
Non-scoringFBIO / S&P -47.71% / 12.04% | Non-scoringFBIO / S&P FBIO unavailable / 23.28 | Non-scoringFBIO / S&P 90.78 / 3.08 | Non-scoringFBIO / S&P FBIO unavailable / $2.92m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.11b |
| 2017-Q22/3 |
WinFBIO / S&P 28.38% / 3.09% |
WinFBIO / S&P 3249.80% / 4.83% |
LoseFBIO / S&P FBIO unavailable / 17.74% |
Non-scoringFBIO / S&P -54.84% / 11.96% | Non-scoringFBIO / S&P FBIO unavailable / 23.40 | Non-scoringFBIO / S&P 49.75 / 3.03 | Non-scoringFBIO / S&P FBIO unavailable / $2.92m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.08b |
| 2017-Q12/3 |
WinFBIO / S&P 37.04% / 6.07% |
WinFBIO / S&P 5814.17% / 3.67% |
LoseFBIO / S&P FBIO unavailable / 13.32% |
Non-scoringFBIO / S&P -90.69% / 11.75% | Non-scoringFBIO / S&P FBIO unavailable / 23.60 | Non-scoringFBIO / S&P 58.49 / 3.01 | Non-scoringFBIO / S&P FBIO unavailable / $2.92m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $20.24b |
| 2016-Q41/3 |
LoseFBIO / S&P -9.09% / 3.82% |
WinFBIO / S&P 1809.62% / 2.09% |
LoseFBIO / S&P FBIO unavailable / 7.05% |
Non-scoringFBIO / S&P -334.31% / 11.37% | Non-scoringFBIO / S&P FBIO unavailable / 23.76 | Non-scoringFBIO / S&P 51.48 / 2.91 | Non-scoringFBIO / S&P FBIO unavailable / $2.88m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $1.11b |
| 2016-Q32/3 |
WinFBIO / S&P 10.41% / 3.85% |
WinFBIO / S&P 700.57% / 0.20% |
LoseFBIO / S&P FBIO unavailable / -3.15% |
Non-scoringFBIO / S&P -1182.49% / 10.82% | Non-scoringFBIO / S&P FBIO unavailable / 24.22 | Non-scoringFBIO / S&P 59.45 / 2.78 | Non-scoringFBIO / S&P FBIO unavailable / $2.88m | Non-scoringFBIO / S&P FBIO unavailable / $0.00b | Non-scoringFBIO / S&P FBIO unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | FBIO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 8.53% | 20.78% |
| Annualized return | 8.53% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | FBIO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -94.49% | 83.14% |
| Annualized return | -44.00% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | FBIO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -93.16% | 319.30% |
| Annualized return | -23.53% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.